Advisors Asset Management Inc. decreased its holdings in CME Group Inc (NASDAQ:CME) by 2.4% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 31,690 shares of the financial services provider’s stock after selling 772 shares during the quarter. Advisors Asset Management Inc.’s holdings in CME Group were worth $5,195,000 at the end of the most recent reporting period.
A number of other institutional investors have also modified their holdings of the business. Edgewood Management LLC raised its stake in CME Group by 2.8% in the 2nd quarter. Edgewood Management LLC now owns 7,840,451 shares of the financial services provider’s stock worth $1,285,207,000 after purchasing an additional 215,439 shares in the last quarter. Janus Henderson Group PLC raised its position in shares of CME Group by 13.2% in the 2nd quarter. Janus Henderson Group PLC now owns 6,129,157 shares of the financial services provider’s stock valued at $1,004,691,000 after buying an additional 716,655 shares in the last quarter. Fiera Capital Corp raised its position in shares of CME Group by 2.8% in the 2nd quarter. Fiera Capital Corp now owns 2,225,333 shares of the financial services provider’s stock valued at $364,777,000 after buying an additional 60,825 shares in the last quarter. Standard Life Aberdeen plc raised its position in shares of CME Group by 38.1% in the 2nd quarter. Standard Life Aberdeen plc now owns 1,765,929 shares of the financial services provider’s stock valued at $289,472,000 after buying an additional 487,442 shares in the last quarter. Finally, Vontobel Asset Management Inc. raised its position in shares of CME Group by 14.3% in the 2nd quarter. Vontobel Asset Management Inc. now owns 1,566,350 shares of the financial services provider’s stock valued at $263,940,000 after buying an additional 195,430 shares in the last quarter. Institutional investors and hedge funds own 84.30% of the company’s stock.
In related news, insider Hilda Harris Piell sold 1,823 shares of CME Group stock in a transaction that occurred on Tuesday, September 4th. The shares were sold at an average price of $175.00, for a total transaction of $319,025.00. Following the sale, the insider now directly owns 30,176 shares of the company’s stock, valued at approximately $5,280,800. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, President Bryan T. Durkin sold 11,509 shares of CME Group stock in a transaction that occurred on Monday, August 6th. The shares were sold at an average price of $162.01, for a total transaction of $1,864,573.09. Following the sale, the president now directly owns 64,862 shares in the company, valued at $10,508,292.62. The disclosure for this sale can be found here. Insiders have sold a total of 29,188 shares of company stock worth $4,973,607 over the last ninety days. 0.43% of the stock is currently owned by insiders.
CME Group (NASDAQ:CME) last announced its quarterly earnings results on Thursday, July 26th. The financial services provider reported $1.74 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.72 by $0.02. The company had revenue of $1.06 billion for the quarter, compared to analyst estimates of $1.05 billion. CME Group had a net margin of 111.45% and a return on equity of 9.03%. The firm’s revenue was up 14.6% on a year-over-year basis. During the same period in the previous year, the firm posted $1.22 EPS. Equities research analysts forecast that CME Group Inc will post 6.57 EPS for the current year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, September 25th. Investors of record on Monday, September 10th were issued a dividend of $0.70 per share. This represents a $2.80 annualized dividend and a dividend yield of 1.55%. The ex-dividend date of this dividend was Friday, September 7th. CME Group’s dividend payout ratio (DPR) is presently 58.70%.
CME has been the subject of several analyst reports. Zacks Investment Research upgraded shares of CME Group from a “sell” rating to a “hold” rating in a research report on Wednesday, October 3rd. Jefferies Financial Group boosted their target price on shares of CME Group to $203.00 and gave the company a “buy” rating in a research report on Monday, October 8th. BidaskClub upgraded shares of CME Group from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, October 9th. Rosenblatt Securities initiated coverage on shares of CME Group in a research report on Wednesday, September 5th. They issued a “neutral” rating and a $177.00 target price for the company. Finally, Deutsche Bank restated a “buy” rating and issued a $192.00 target price (up from $185.00) on shares of CME Group in a research report on Thursday, October 11th. Five analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average target price of $181.38.
About CME Group
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Recommended Story: What are retained earnings?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.